26-week Open Study of telmisartan40mg+amlodipine10mg or telmisartan80mg+amlodipine10 mg in Hypertension

NCT00624052 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

838

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: fixed-dose combination of telmisartan 40mg+amlodipine 10mg
DRUG: fixed-dose combination of telmisartan 80mg+amlodipine10mg

Sponsor

Boehringer Ingelheim